According to Gram Research analysis, a special mixture of multiple fiber types significantly reduced intestinal inflammation and increased regulatory T cells—immune cells that calm inflammation—in mice with Crohn’s disease-like colitis. The fiber mixture worked by changing gut bacteria composition, which reduced a chemical that normally blocks the development of these protective immune cells. While these results are promising, human studies are needed before this fiber mixture can be recommended as a Crohn’s disease treatment.
Researchers discovered that a special mixture of different fibers could help reduce inflammation in Crohn’s disease by changing how the immune system works. Using mice bred to develop Crohn’s-like symptoms, scientists found that the fiber mixture helped the body create more regulatory T cells—immune cells that calm down inflammation. The fibers worked by changing the gut bacteria and affecting how genes are controlled at a molecular level. This research suggests that eating the right combination of fibers might be a natural way to help manage Crohn’s disease symptoms, though human studies are still needed to confirm these findings.
Key Statistics
A 2026 research article in the European Journal of Nutrition found that a special multifiber mixture significantly reduced intestinal inflammation and restored epithelial barrier function in mice genetically engineered to develop Crohn’s-like colitis.
According to the 2026 study, the fiber mixture promoted regulatory T cell differentiation while simultaneously suppressing Th1/Th17 immune cells that drive inflammation in Crohn’s disease.
Gram Research analysis of the 2026 study identified that the fiber mixture reduced SAM (S-adenosylmethionine) levels and m6A methylation on ETS1 messenger RNA, leading to decreased ETS1 expression and increased Foxp3 expression—the master switch for creating regulatory T cells.
The 2026 research confirmed that the ETS1/RUNX1/Foxp3 gene interaction pattern identified in mice also appears in intestinal tissue samples from actual patients with Crohn’s disease, suggesting the mechanism may be relevant to human disease.
The Quick Take
- What they studied: Whether a special mixture of multiple types of fiber could reduce inflammation and improve immune function in mice with Crohn’s disease-like colitis
- Who participated: Laboratory mice genetically engineered to develop Crohn’s-like intestinal inflammation, used as a disease model to test the fiber mixture’s effects
- Key finding: The fiber mixture significantly reduced intestinal inflammation, restored the intestinal barrier, and increased the number of regulatory T cells—immune cells that help control inflammation
- What it means for you: This research suggests that specific fiber combinations might help manage Crohn’s disease by naturally boosting the immune system’s ability to reduce inflammation, though human studies are needed before this can be recommended as a treatment
The Research Details
Scientists used mice that were genetically modified to lack a protein called interleukin-10, which naturally causes them to develop Crohn’s-like intestinal inflammation. These mice were fed a special mixture of different fibers while researchers carefully measured what happened to their immune system, gut bacteria, and intestinal health. The team used advanced laboratory techniques to examine immune cell types, analyze which genes were turned on or off, study the bacteria living in the gut, and measure chemical modifications to genetic material. This comprehensive approach allowed them to understand not just whether the fiber mixture worked, but exactly how it worked at the molecular level.
The researchers compared mice eating the fiber mixture to control mice eating regular food, tracking changes over time. They examined intestinal tissue samples, blood samples, and stool samples to get a complete picture of how the fiber mixture affected the body. By using multiple measurement methods simultaneously, they could identify the specific biological pathways involved in the healing process.
This study design is important because it goes beyond simply showing that something works—it reveals the exact biological mechanisms involved. Understanding how the fiber mixture changes gut bacteria, which then affects gene regulation and immune cell development, provides a roadmap for developing better treatments. The use of a mouse model that naturally develops Crohn’s-like disease makes the findings more relevant to human disease than simpler laboratory tests would be.
This is a well-designed laboratory study published in a respected nutrition journal. The researchers used multiple advanced techniques to measure different aspects of the disease and healing process, which strengthens their conclusions. However, this is animal research, so results may not directly translate to humans. The study provides strong evidence for a biological mechanism but should be followed by human clinical trials before the fiber mixture is recommended as a treatment.
What the Results Show
The special fiber mixture produced dramatic improvements in the mice with Crohn’s-like disease. Intestinal inflammation was significantly reduced compared to mice eating regular food. The fiber mixture also helped repair the intestinal barrier—the protective lining that prevents harmful bacteria from entering the bloodstream, which is often damaged in Crohn’s disease.
Most importantly, the fiber mixture increased the number of regulatory T cells, which are immune cells that act like peacekeepers in the body, calming down excessive inflammation. At the same time, the mixture reduced harmful immune cells called Th1 and Th17 cells that drive inflammation in Crohn’s disease. This shift in the immune system balance appears to be the key to how the fiber mixture helps.
The researchers discovered the detailed mechanism: the fiber mixture changed the composition of gut bacteria, which reduced levels of a chemical called SAM (S-adenosylmethionine). Lower SAM levels meant less chemical modification of a gene called ETS1. When ETS1 expression decreased, it allowed another gene called Foxp3 to increase, which is the master switch for creating regulatory T cells. This chain reaction—fiber → bacteria changes → SAM reduction → ETS1 decrease → Foxp3 increase → more regulatory T cells—explains how the mixture works.
The study also found that RUNX1, another gene involved in immune regulation, worked together with ETS1 in controlling regulatory T cell development. The researchers confirmed this gene interaction pattern not only in their mouse model but also in actual intestinal tissue samples from patients with Crohn’s disease, suggesting the mechanism may be relevant to human disease. The fiber mixture’s ability to reshape the gut microbiota—the community of bacteria living in the intestines—appears to be the starting point for all the beneficial effects that follow.
Previous research has shown that regulatory T cells are crucial for preventing Crohn’s disease and that gut bacteria play an important role in immune health. This study builds on that knowledge by identifying a specific biological pathway connecting fiber intake, bacterial changes, gene regulation, and immune cell development. The discovery of the ETS1/RUNX1/Foxp3 axis as a key control point is new and provides a more detailed understanding than previous studies. The finding that m6A methylation (a chemical modification of genetic material) is involved in this process represents an emerging area of research in understanding how diet affects gene expression.
This research was conducted entirely in mice, not humans, so the results may not directly apply to people with Crohn’s disease. The specific fiber mixture tested would need to be studied in human clinical trials before it could be recommended as a treatment. The study doesn’t specify the exact composition of the fiber mixture, which makes it difficult for other researchers to replicate the work or for patients to know what to use. Additionally, the study used mice genetically engineered to develop disease, which may not perfectly mirror how Crohn’s disease develops in humans through a combination of genetics and environmental factors. The research also doesn’t address whether the fiber mixture would work in people already taking medications for Crohn’s disease or how it might interact with existing treatments.
The Bottom Line
Based on this research, increasing dietary fiber intake—particularly from diverse sources—may help support immune health and reduce inflammation in people with Crohn’s disease. However, this is preliminary evidence from animal studies. People with Crohn’s disease should not change their diet or stop medications based on this research alone. Instead, discuss with your gastroenterologist whether increasing fiber intake might be appropriate for your specific situation, as fiber can sometimes trigger symptoms in people with active Crohn’s disease. The confidence level for this recommendation is moderate—the biological mechanism is well-demonstrated in mice, but human evidence is still needed.
This research is most relevant to people with Crohn’s disease, their families, and healthcare providers treating inflammatory bowel disease. Researchers studying how diet affects immune function and gut health should also pay attention to these findings. People without Crohn’s disease may benefit from the general principle that diverse fiber intake supports gut health, but this study doesn’t provide specific evidence for that population. People with severe active Crohn’s disease should be cautious about increasing fiber without medical guidance, as it can sometimes worsen symptoms during flare-ups.
In the mouse model, improvements in inflammation and immune function were measurable within the study period, but the exact timeline isn’t specified in the abstract. If this were to be tested in humans, it would likely take weeks to months to see meaningful improvements in symptoms, as changes in gut bacteria and immune function happen gradually. Long-term studies would be needed to determine if benefits persist with continued use.
Frequently Asked Questions
Can eating more fiber help treat Crohn’s disease?
This research shows a special fiber mixture reduced inflammation in mice with Crohn’s disease by boosting immune cells that calm inflammation. However, this is animal research only. People with Crohn’s disease should consult their doctor before increasing fiber, as it can sometimes trigger symptoms during flare-ups.
How does fiber reduce Crohn’s disease inflammation?
According to the 2026 study, fiber changes gut bacteria composition, which reduces a chemical called SAM. Lower SAM levels allow genes controlling regulatory T cells to activate, creating more immune cells that calm inflammation rather than trigger it.
What is the best fiber mixture for inflammatory bowel disease?
This study tested a specific multifiber mixture but doesn’t detail its exact composition. The research is preliminary and only tested in mice. Consult your gastroenterologist about which fiber sources are appropriate for your individual Crohn’s disease, as tolerance varies greatly between people.
When will this fiber treatment be available for Crohn’s disease patients?
This is early-stage research conducted in mice. Human clinical trials would be needed before any fiber mixture could be recommended as a Crohn’s disease treatment. This process typically takes several years, so this specific treatment is not yet available for patients.
Does this research apply to other types of inflammatory bowel disease?
This study specifically examined Crohn’s disease using a mouse model. While the immune mechanisms may be similar in ulcerative colitis, the research doesn’t directly test that condition. People with other forms of IBD should discuss these findings with their healthcare provider.
Want to Apply This Research?
- Track daily fiber intake by type (soluble vs. insoluble, and specific sources like oats, beans, vegetables, fruits) alongside symptom severity scores (abdominal pain, bowel movement frequency, energy levels) to identify personal patterns between fiber consumption and symptom changes
- Gradually increase fiber intake from diverse sources while monitoring symptoms, using the app to log which specific fibers seem well-tolerated versus those that trigger symptoms, allowing personalized optimization of fiber intake for your individual Crohn’s disease management
- Maintain a 12-week food and symptom diary within the app, tracking fiber types and amounts daily while rating inflammation symptoms, energy, and bowel function on a 1-10 scale to identify your personal fiber tolerance threshold and optimal fiber sources
This research was conducted in mice with genetically engineered Crohn’s disease and has not been tested in humans. The findings are preliminary and should not be used to guide treatment decisions. People with Crohn’s disease should not change their diet, start new supplements, or modify medications based on this research without consulting their gastroenterologist. Increasing fiber intake can trigger symptoms in some people with active Crohn’s disease. This article is for educational purposes only and does not constitute medical advice. Always work with your healthcare provider to develop a treatment plan appropriate for your individual condition.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.